A clinical validation study of more than 350 dogs suggests blood-based testing could increase preclinical cancer detection
|
The novel therapy may have an impact on how cancer can be treated in both humans and pets
|
Petco Love and Blue Buffalo will match contributions up to $100,000 for Morris Animal Foundation’s ‘Stop Cancer Furever’
|
PetDx’s proprietary OncoK9 has a sensitivity of 85.4 per cent for canine lymphoma, hemangiosarcoma, and osteosarcoma
|
Texas A&M has introduced a simplified oncology test that allows for early diagnosis in dogs
|
Risks associated with exposure to common environmental chemicals vary from dog to dog, new Morris Animal Foundation research suggests
|
The method will allow veterinarians to develop optimum treatment plans for canine cancer patients
|
Texas A&M’s veterinary college is developing a blood test to identify early cancer in dogs
|
The Ontario-based company is teaming up with Iowa State University College of Veterinary Medicine to conduct a clinical study
|
Dog deemed cancer-free after Echopulse
|
KPT-9274, combined with just one round of chemotherapy, is the focus of treating lymphoma in a clinical trial
|
The multi-year grant will support the largest-ever interventional canine clinical trial
|
Funds from the Blue Buffalo Foundation will help researchers develop more effective drug therapies
|
Oakland Veterinary Referral Services is looking nationwide for dogs suffering from stage II splenic hemangiosarcoma to submit for study, herbal treatment
|
The grant will fund a study aimed at understanding the interactions between cancer and the immune system in dogs with naturally occurring tumors
|
What the veterinary experts are hoping we learn from cancer in dogs that will later benefit humans
|
|
|
